CASPR2 antibody-related movement disorders: case series

Affiliations

¹ University Hospitals Birmingham NHS Trust, Queen Elizabeth University Hospital Mindelsohn Way Edgbaston, Birmingham, B15 2GW, England. Sangeeta1@doctors.net.uk.
² College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, England.
³ Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.
⁴ University of Manchester, Manchester, UK.
⁵ Royal Wolverhampton NHS Trust, Wolverhampton Road, Wolverhampton, West Midlands, WV10 0QP, England.
⁶ University Hospitals Birmingham NHS Trust, Queen Elizabeth University Hospital Mindelsohn Way Edgbaston, Birmingham, B15 2GW, England.
⁷ Department of Neurology, Sree Chitra Tirunal Institute of Medical Sciences and Technology, Kerala, 695011, India.

Sangeeta Scotton et al. J Neurol. 2021 Apr.

. 2021 Apr;268(4):1533-1535.

doi: 10.1007/s00415-020-10357-w. Epub 2021 Jan 5.

¹ University Hospitals Birmingham NHS Trust, Queen Elizabeth University Hospital Mindelsohn Way Edgbaston, Birmingham, B15 2GW, England. Sangeeta1@doctors.net.uk.
² College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, England.
³ Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.
⁴ University of Manchester, Manchester, UK.
⁵ Royal Wolverhampton NHS Trust, Wolverhampton Road, Wolverhampton, West Midlands, WV10 0QP, England.
⁶ University Hospitals Birmingham NHS Trust, Queen Elizabeth University Hospital Mindelsohn Way Edgbaston, Birmingham, B15 2GW, England.
⁷ Department of Neurology, Sree Chitra Tirunal Institute of Medical Sciences and Technology, Kerala, 695011, India.

No abstract available

References

1. Balint B, Vincent A, Meinck HM, Irani SR, Bhatia KP (2018) Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology. Brain 141(1):13–36. https://doi.org/10.1093/brain/awx189.PMID:29053777;PMCID:PMC5888977 - DOI - PubMed
1. Muñiz-Castrillo S, Joubert B, Elsensohn M et al (2020) Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features Journal of Neurology. Neurosurg Psychiatry 91:1076–1084 - DOI
1. Boyko M, Au KLK, Casault C et al (2020) Systematic review of the clinical spectrum of CASPR2 antibody syndrome. J Neurol 267:1137–1146. https://doi.org/10.1007/s00415-019-09686-2 - DOI - PubMed
1. Hines H, Murray NM, Ahmad S, Jaradeh S, Gold CA (2018) Video NeuroImages: Paraneoplastic spinal myoclonus associated with Caspr2 antibodies. Neurology [Internet]. [cited 2020 Jun 25];90(14):660–1. https://pubmed.ncbi.nlm.nih.gov/29610228/
1. Gövert F, Witt K, Erro R, Hellriegel H, Paschen S, Martinez-Hernandez E, et al (2016) Orthostatic myoclonus associated with Caspr2 antibodies [Internet]. Neurology. Lippincott Williams and Wilkins [cited 2020 Jun 25]. 86: 1353–5. https://pubmed.ncbi.nlm.nih.gov/26944274/